These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 24274717)
1. Fatty acid binding protein 7 as a marker of glioma stem cells. Morihiro Y; Yasumoto Y; Vaidyan LK; Sadahiro H; Uchida T; Inamura A; Sharifi K; Ideguchi M; Nomura S; Tokuda N; Kashiwabara S; Ishii A; Ikeda E; Owada Y; Suzuki M Pathol Int; 2013 Nov; 63(11):546-53. PubMed ID: 24274717 [TBL] [Abstract][Full Text] [Related]
2. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma. Liang Y; Bollen AW; Aldape KD; Gupta N BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952 [TBL] [Abstract][Full Text] [Related]
3. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells. Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773 [TBL] [Abstract][Full Text] [Related]
4. FABP7 Facilitates Uptake of Docosahexaenoic Acid in Glioblastoma Neural Stem-like Cells. Choi WS; Xu X; Goruk S; Wang Y; Patel S; Chow M; Field CJ; Godbout R Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444824 [TBL] [Abstract][Full Text] [Related]
5. Regulation of the FABP7 gene by PAX6 in malignant glioma cells. Liu RZ; Monckton EA; Godbout R Biochem Biophys Res Commun; 2012 Jun; 422(3):482-7. PubMed ID: 22583899 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Fatty Acid Synthase Decreases Expression of Stemness Markers in Glioma Stem Cells. Yasumoto Y; Miyazaki H; Vaidyan LK; Kagawa Y; Ebrahimi M; Yamamoto Y; Ogata M; Katsuyama Y; Sadahiro H; Suzuki M; Owada Y PLoS One; 2016; 11(1):e0147717. PubMed ID: 26808816 [TBL] [Abstract][Full Text] [Related]
7. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro. Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013 [TBL] [Abstract][Full Text] [Related]
8. A radial glia gene marker, fatty acid binding protein 7 (FABP7), is involved in proliferation and invasion of glioblastoma cells. De Rosa A; Pellegatta S; Rossi M; Tunici P; Magnoni L; Speranza MC; Malusa F; Miragliotta V; Mori E; Finocchiaro G; Bakker A PLoS One; 2012; 7(12):e52113. PubMed ID: 23284888 [TBL] [Abstract][Full Text] [Related]
9. Brain fatty acid-binding protein and omega-3/omega-6 fatty acids: mechanistic insight into malignant glioma cell migration. Mita R; Beaulieu MJ; Field C; Godbout R J Biol Chem; 2010 Nov; 285(47):37005-15. PubMed ID: 20834042 [TBL] [Abstract][Full Text] [Related]
10. Stationary-to-migratory transition in glioblastoma stem-like cells driven by a fatty acid-binding protein 7-RXRα neurogenic pathway. Liu RZ; Choi WS; Jain S; Xu X; Elsherbiny ME; Glubrecht DD; Tessier AG; Easaw JC; Fallone BG; Godbout R Neuro Oncol; 2023 Dec; 25(12):2177-2190. PubMed ID: 37499046 [TBL] [Abstract][Full Text] [Related]
11. The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells. Sullivan KE; Rojas K; Cerione RA; Nakano I; Wilson KF Oncotarget; 2017 Apr; 8(14):22325-22343. PubMed ID: 28423611 [TBL] [Abstract][Full Text] [Related]
12. Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells. Yamamuro S; Sano E; Okamoto Y; Ochiai Y; Ohta T; Ogino A; Natsume A; Wakabayashi T; Ueda T; Hara H; Nakayama T; Yoshino A; Katayama Y Int J Oncol; 2015 Nov; 47(5):1647-54. PubMed ID: 26397698 [TBL] [Abstract][Full Text] [Related]
13. Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer. Alshareeda AT; Rakha EA; Nolan CC; Ellis IO; Green AR Breast Cancer Res Treat; 2012 Jul; 134(2):519-29. PubMed ID: 22562177 [TBL] [Abstract][Full Text] [Related]
14. Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma. Nagao K; Shinohara N; Smit F; de Weijert M; Jannink S; Owada Y; Mulders P; Oosterwijk E; Matsuyama H BMC Cancer; 2018 Nov; 18(1):1114. PubMed ID: 30442117 [TBL] [Abstract][Full Text] [Related]
15. Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner. Nabissi M; Morelli MB; Amantini C; Liberati S; Santoni M; Ricci-Vitiani L; Pallini R; Santoni G Int J Cancer; 2015 Oct; 137(8):1855-69. PubMed ID: 25903924 [TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth. Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911 [TBL] [Abstract][Full Text] [Related]
18. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs. Zhao B; Bian EB; Li J; Li J J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932 [TBL] [Abstract][Full Text] [Related]
19. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting. Balasubramaniyan V; Vaillant B; Wang S; Gumin J; Butalid ME; Sai K; Mukheef F; Kim SH; Boddeke HW; Lang F; Aldape K; Sulman EP; Bhat KP; Colman H Oncotarget; 2015 Oct; 6(31):31007-17. PubMed ID: 26307681 [TBL] [Abstract][Full Text] [Related]
20. Identification of FABP7 as a Potential Biomarker for Predicting Prognosis and Antiangiogenic Drug Efficacy of Glioma. Hou L; Zhou H; Wang Y; Liu J; Zhang D; Li Y; Xue X Dis Markers; 2022; 2022():2091791. PubMed ID: 35783014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]